Literature DB >> 15256034

Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units.

Kuo-Ming Yeh1, L K Siu, Jen-Chang Chang, Feng-Yee Chang.   

Abstract

From July, 1997, through December, 2001, patients who were admitted to intensive care units (ICUs) were enrolled in the study of vancomycin resistance enterococcus (VRE) colonization. Among 4,538 patients admitted to the ICUs, 363 (8.0%) patients were found to have positive culture of VRE at the day of admission to the ICUs and 453 (10.0%) of patients were negative to the first day of admission but became colonized with VRE during the stay in ICU. Among 816 patients, 9 (1.1%) with VRE isolated from sterile sites were selected for further analysis. Pulsed-field gel electrophoresis (PFGE) revealed a total of four PFGE banding patterns in the colonized and infected Enterococcus faecium isolates. Six of nine 9 were found to have an identical PFGE type Ia, suggesting the circulation of an endemic strain. All of these type Ia isolates also contained two potential virulence genes, the esp and hly genes and were first identified in Asia. After the further typing of 540 isolates that were randomly selected from each month, the endemic strain was not identified before the first patient was colonized and infected with this strain in November, 1998, but was isolated from other ICU patients during each month thereafter throughout the remainder of the study period. Although colonization of VRE is the first step toward infection, a low infection rate was observed, except in patients with prolonged hospitalization and severe illness. Use of the isolation room and reminders regarding hand hygiene failed to prevent the circulation of endemic strain. Thus, the SHEA guideline (Muto et al., Infect. Control Hosp. Epidemiol. 2003;24:362-386) for preventing nosocomial transmission of VRE should be enforced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256034     DOI: 10.1089/1076629041310091

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

Review 1.  Vancomycin-resistant enterococci (VRE): a reason to isolate?

Authors:  Maria J G T Vehreschild; Miriam Haverkamp; Lena M Biehl; Sebastian Lemmen; Gerd Fätkenheuer
Journal:  Infection       Date:  2018-09-03       Impact factor: 3.553

2.  Impact of the reduction of environmental and equipment contamination on vancomycin-resistant enterococcus rates.

Authors:  M R E Perugini; S M Nomi; G K Lopes; R A Belei; I M van der Heijden; A K Q Mostachio; C Grion; E B Couto; S F Costa
Journal:  Infection       Date:  2011-08-17       Impact factor: 3.553

3.  Clonal spread of CC17 vancomycin-resistant Enterococcus faecium with multilocus sequence type 78 (ST78) and a novel ST444 in Taiwan.

Authors:  Y-C Hsieh; W-S Lee; T-Y Ou; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-15       Impact factor: 3.267

4.  Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization.

Authors:  Elizabeth Short; John Esterly; Michael Postelnick; Jeannie Ong; Milena McLaughlin
Journal:  Antimicrob Resist Infect Control       Date:  2014-12-01       Impact factor: 4.887

5.  Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital.

Authors:  Sofia Maraki; George Samonis; Dimitra Dimopoulou; Elpis Mantadakis
Journal:  Infect Chemother       Date:  2014-12-29

Review 6.  Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

7.  Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.

Authors:  Panayiotis D Ziakas; Rachana Thapa; Louis B Rice; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

8.  Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: a systematic review and meta-analysis.

Authors:  Addisu Melese; Chalachew Genet; Tesfaye Andualem
Journal:  BMC Infect Dis       Date:  2020-02-11       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.